|
|
Assessing immunogenicity of LepVax: a new leprosy vaccine in clinical development |
| 5 R21 AI144641-02 |
DUTHIE, MALCOLM S |
NIAID |
2021 |
|
|
Interpretation and Utility of Novel Composite Structural Endpoints of Cumulative Damage and Disease Activity in Knee Osteoarthritis |
| 1 R01 AR076411-01A1 |
DRIBAN, JEFFREY B |
NIAMS |
2021 |
|
|
Smad signaling in skeletal muscle laminopathies |
| 5 R21 AR075193-02 |
WALLRATH, LORI L |
NIAMS |
2021 |
|
|
Mediator kinases as interferon antagonists in Down Syndrome |
| 1 R01 AI156739-01 |
TAATJES, DYLAN J |
NIAID |
2020 |
|
|
Identification of complex cellular phenotypes and their interactions in MS lesions |
| 1 R21 AI149731-01 |
PITT, DAVID |
NIAID |
2020 |
|
|
A Cellular Pilot of Human T Lymphocytes |
| 1 R21 AI149771-01A1 |
CHEN, YOUHAI H |
NIAID |
2020 |
|
|
Induction of antiprotozoal secondary metabolites from endophytic fungi using epigenetic modifiers |
| 1 R21 AI154179-01 |
BAKER, BILL J |
NIAID |
2020 |
|
|
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus |
| 1 R01 AR076475-01A1 |
LEDOUX, WILLIAM R |
NIAMS |
2020 |
|
|
New Directions in Biology and Disease of Skeletal Muscle |
| 1 R13 AR078066-01 |
MCNALLY, ELIZABETH M |
NIAMS |
2020 |
|
|
Nanoscale organization and mechanotransduction of emerin at the nuclear envelope: Implication for Emery-Dreifuss Muscular Dystrophy |
| 1 R21 AR076514-01 |
PINAUD, FABIEN |
NIAMS |
2020 |
